HIP-1701
N/A
Report date: 2023/11/28 20:05:47
NME
Base Information
Drug NameHIP-1701
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A